We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · September 02, 2021

Novel Bioenhanced Curcumin With Mesalamine for Induction of Remission in Mild-to-Moderate Ulcerative Colitis

Journal of Clinical Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Gastroenterology
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study
J. Clin. Gastroenterol. 2020 Sep 04;[EPub Ahead of Print], R Banerjee, P Pal, A Penmetsa, P Kathi, G Girish, I Goren, DN Reddy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading